High-efficiency derivation of human embryonic stem cell lines following pre-implantation genetic diagnosis.
about
Modeling Kidney Disease with iPS CellsModelling human disease with pluripotent stem cellsAllele-specific silencing of mutant huntingtin in rodent brain and human stem cellsModeling Fragile X Syndrome Using Human Pluripotent Stem CellsInduced pluripotent stem cells--opportunities for disease modelling and drug discovery.Modelling familial dysautonomia in human induced pluripotent stem cells.Female sex bias in human embryonic stem cell lines.A Euploid Line of Human Embryonic Stem Cells Derived from a 43,XX,dup(9q),+12,-14,-15,-18,-21 EmbryoIn vitro modeling of hyperpigmentation associated to neurofibromatosis type 1 using melanocytes derived from human embryonic stem cellsHuman pluripotent stem cells: applications and challenges in neurological diseases.Vitrified blastocysts from Preimplantation Genetic Diagnosis (PGD) as a source for human Embryonic Stem Cell (hESC) derivation.Reprogrammed cells for disease modeling and regenerative medicine.Directed differentiation of pluripotent stem cells to kidney cells.Aneuploid human embryonic stem cells: origins and potential for modeling chromosomal disorders.Human pluripotent stem cells for genetic disease modeling and drug screening.Human pluripotent stem cells for disease modelling and drug screening.Standardization of pluripotent stem cell cultures for toxicity testing.In vitro uses of human pluripotent stem cell-derived cardiomyocytes.Substrates and supplements for hESCs: a critical reviewModeling neurodevelopmental disorders using human pluripotent stem cells.Concise Review: Patient-Derived Stem Cell Research for Monogenic Disorders.Huntington Disease as a Neurodevelopmental Disorder and Early Signs of the Disease in Stem Cells.Human embryonic stem cells carrying an unbalanced translocation demonstrate impaired differentiation into trophoblasts: an in vitro model of human implantation failure.Early transcriptional changes linked to naturally occurring Huntington's disease mutations in neural derivatives of human embryonic stem cells.Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids.Derivation of human embryonic stem cells using a post-inner cell mass intermediate.
P2860
Q54970607-A8073E2F-7535-4617-B3B1-567E7BEF74E7Q54970609-64920B7E-7C5A-4722-AA1F-593ED6B83E2AQ54970610-67B4152B-2A97-4172-B61F-C895BB65E627Q54970611-8C03356D-1FA6-4A3F-B959-DE56FF805F29Q54970612-F0AC57B6-6155-4D70-AB4E-306DF9AF70E4Q54970613-6E2B383E-2196-4859-8669-53D10458444EQ54970615-1FA445EB-5A8E-4045-B2C8-8D9F292E8C09Q54970623-1C640422-1E20-4386-BE7A-CC97D423E399Q54970624-96A8B618-856F-4239-B952-514746AE56BDQ54970625-AC1CC738-98CD-47B8-8FC8-7488D8DD1C42Q54970626-215510D2-5A62-48DF-9948-FBD0C72A091F
P1343
Q26770384-9BCA08FE-1484-47A0-AC2F-2F2FF5916B4BQ26864380-6133789A-2A09-4D3C-9BAD-4FDB75CE612EQ27324212-DC00850F-4446-40A9-8DA2-66A778C1F1B2Q28080022-3DECB27B-DFEE-474D-8C0F-4666D86E19F9Q34231818-D08E2D0E-5442-497D-BF2E-C2EFD3E86830Q35088526-42722AEA-2A8E-4AEE-BE82-E6D640DDC589Q35737463-A498FF47-5030-45C5-B821-FB089FFDE117Q35833657-2E3C7637-8CF1-46AD-B04B-A8CD1352C05DQ35895599-B434E345-A9CA-4766-A13A-A3AE350A2621Q36193696-04C3B18B-DA1A-4E3B-8AD1-0BD93ECFD306Q36381564-A05061C3-A52A-46F0-9608-262B238D53FDQ36776248-21E18FE7-96B1-4424-9AA6-AD30ABC4A4A5Q36969401-4B9C9A57-E301-4455-BDAD-DC2986034007Q37900302-2494FE96-A972-4EC6-B325-003FA8766417Q37931912-793381D3-0217-440D-9A42-713FF3B24F0AQ37950950-BACEAD95-624F-489E-8669-B302142A8358Q37976119-7910588A-8DF3-4CB6-AC0C-55761B22B266Q38013733-D9F09E88-1FF0-471A-B2D7-41D9FA80C48CQ38071592-B731563F-B38E-4DCF-A424-EF8A72B3F944Q38204302-66373B5E-5163-4741-B2CA-700B1E2639B8Q38557791-DE589A32-CB6F-46DE-BC3F-6A5DBF758129Q38790183-65281B3F-459F-4499-AEB7-1515DEC5B9A6Q38940959-CB7369FB-4234-4D5F-892A-532EDCFE4E71Q39335116-530ECFFF-C5FD-4E1B-AF67-32F2187ACB2CQ41623746-F78520A1-2A11-40B5-87D6-F52426ED84B7Q49140126-33F4B0E6-B30C-4C87-B6D6-7A9FF8B2FA32
P2860
High-efficiency derivation of human embryonic stem cell lines following pre-implantation genetic diagnosis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
High-efficiency derivation of ...... mplantation genetic diagnosis.
@en
High-efficiency derivation of ...... mplantation genetic diagnosis.
@nl
type
label
High-efficiency derivation of ...... mplantation genetic diagnosis.
@en
High-efficiency derivation of ...... mplantation genetic diagnosis.
@nl
prefLabel
High-efficiency derivation of ...... mplantation genetic diagnosis.
@en
High-efficiency derivation of ...... mplantation genetic diagnosis.
@nl
P2093
P4510
P1476
High-efficiency derivation of ...... implantation genetic diagnosis
@en
P2093
Christine Varela
Céline Moutou
Johana Tournois
Marc Peschanski
Michel Cailleret
Pascal Fragner
Philippe Tropel
Stéphane Viville
Yacine Laâbi
P2888
P304
P356
10.1007/S11626-010-9300-8
P4510
P50
P577
2010-03-09T00:00:00Z